Ludivine S. Breger

Bordeaux, 33000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Evaluation of blood flow as a route for propagation in experimental synucleinopathy.

Evaluation of blood flow as a route for propagation in experimental synucleinopathy.

Journal: Neurobiology of disease
Published: November 16, 2020

Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE.

Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE.

Journal: Heliyon
Published: September 10, 2020

Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD.

Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 17, 2020

Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates.

Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates.

Journal: Neurobiology of disease
Published: February 13, 2020

Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates.

Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates.

Journal: Neurobiology of disease
Published: December 09, 2019

Genetically engineered animal models of Parkinson's disease: From worm to rodent.

Genetically engineered animal models of Parkinson's disease: From worm to rodent.

Journal: The European journal of neuroscience
Published: May 16, 2018

Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats.

Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats.

Journal: Scientific reports
Published: March 15, 2018

GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration.

GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration.

Journal: Gene therapy
Published: February 12, 2018

Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain.

Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain.

Journal: Molecular therapy. Methods & clinical development
Published: December 05, 2017

Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.

Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 14, 2017

Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease.

Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease.

Journal: Brain, behavior, and immunity
Published: July 08, 2016

A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses.

A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses.

Journal: Molecular therapy. Methods & clinical development
Published: January 15, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026